PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 76: Articles 37501-38000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. An overview of evaluative studies in family planning training in Asia.
  2. Overview of the medical and clinical activities performed by the family planning associations of the Western Hemisphere Region, January 1-December 31, 1971.
  3. Ovulation method of family planning [letter]
  4. Ovulation method of family planning [letter]
  5. Ovulation method of family planning [letter]
  6. Ovulation method of family planning. (Letter to the editor)
  7. Ovulation method of family planning. (Letter to the editor)
  8. The ovum, the uterus and birth control.
  9. Papua and New Guinea (Family planning)
  10. Parenteral contraception with depot-gestagens.
  11. Parity, contraception and infant mortality.
  12. Parliament: comments on contraceptives.
  13. Participation of the ventromedial hippocampus in reproduction and contraception. [Uchastie ventromedialnio chasti gippokampa v funktsii reproduktsii i effekte kontratseptsii.]
  14. The pathology of intracranial venous thrombosis in oral contraception.
  15. The pediatrician and family planning in a very poor community: an appraisal of experiences in the Tufts Delta Health Center, Bolivar County, Mississippi.
  16. Peoples' objections to family planning and how to overcome them.
  17. Performance of loop and shield intrauterine contraceptive devices.
  18. The performance record. (Contraception)
  19. Personality patterns of couples practicing the temperature-rhythm method of birth control.
  20. The pharmacist and contraception. [La pharmacien devant la contraception.]
  21. Pharmacists' attitudes and practices toward contraceptives.
  22. The Philippines: within and beyond family planning.
  23. Physical contraceptive methods. [Les methodes physiques de contraception.]
  24. Physician survey on family planning.
  25. Physiological and social aspects of family planning. A Muslim Arab point of view.
  26. The physiologist and contraception.
  27. Pigment changes associated with oral contraceptives. [Klinik der Pigmentveraenderungen durch orale Kontrazeptiva.]
  28. Pill a month as an oral contraceptive.
  29. Pill-a-month as an oral contraceptive.
  30. Place of IUCD in the early post-partum contraception.
  31. A Planned Parenthood abortion service.
  32. The Planned Parenthood Federation of Korea.
  33. Planned parenthood from the pediatrician's point of view. [Planovane rodicovstvo zo strany pediatra.]
  34. Planned parenthood from the sexologist's point of view. [Planovane rodicovstvo z hladiska sexuologa.]
  35. Planned parenthood in Colombia, South America.
  36. Planned parenthood pipedream. (Letter to the editor)
  37. Planned parenthood services for the young teenager.
  38. Planned Parenthood-World Population Inter-regional statistical report, 1970.
  39. Planned parenthood. [Planovane rodicovstvo.]
  40. Planning family planning.
  41. The planning family. Goal of family planning.
  42. Plans for a cohort investigation of abnormal cervical cytology among users of different methods of birth control.
  43. Plasma ascorbic acid concentrations and oral contraceptives.
  44. Plasma hormone concentrations in women receiving steroid contraceptives.
  45. Plasma lipids and lipoproteins in bilharzial females during oral contraceptive therapy.
  46. Plasma lipids and lipoproteins in bilharzial females during oral contraceptive therapy. contraceptive therapy.
  47. Plasma renin concentration, activity, and substrate in hypertension induced by oral contraceptives.
  48. Politician and family planning.
  49. Polling Americans on birth control and population.
  50. The poor as a "perfect contraceptive population" and zero population growth.
  51. Population and family planning education in India.
  52. Population and family planning education. Report of a seminar at Holte, Denmark, July 3-28, 1972.
  53. Population and family planning programs: a factbook. 4th edition.
  54. Population and family planning: growing involvement of psychologists.
  55. Population attitudes toward birth control in pre-industrial France and England.
  56. Population education-family planning curriculum in nursing education in India.
  57. Population policies and family planning programmes.
  58. The population problem and family planning effort with particular reference to India.
  59. The population problem and family planning effort.
  60. Population problems and family planning in Africa.
  61. Population project annual report: 1971-1972. Interaction of health services and family planning at the village level.
  62. Possibilities in the wider use of the temperature control method of contraception control. [Moznost sirsiho vyuzivani teplotni metody regulace poceti.]
  63. Possibilities: family planning or population control?
  64. Possible carcinogenic action of contraceptives. [Sur l'action cancerigene possible des contraceptifs.]
  65. Possible effects of mass media on contraceptive behavior: a preliminary review of research.
  66. Possible genetic effects of some contraceptive methods.
  67. Post oral contraceptive amenorrhea.
  68. Post-coital contraception.
  69. Post-Partum Family Planning: a report on the International Program. (Abstract only)
  70. Postovulatory contraception in women with large doses of norethindrone.
  71. The postpartum approach to family planning.
  72. Postpartum services within family planning programs: present state of the question. [Les services postpartum dans le cadre du planning familial: etat actuel de la question.]
  73. Potential of CMAI member mission hospitals in family planning programme at all India level.
  74. Powerlessness and regularity of contraception in an urban Negro male sample: a research note.
  75. Practical experience with a new contraceptive of a modified sequential type. [Experiences pratiques avec un nouveau contraceptif du type sequential modifie.]
  76. Pregnancy, oral contraceptives, and chronic familial jaundice with predominantly conjugated hyperbilirubinemia (Dubin-Johnson Syndrome)
  77. Pregnancy, the puerperium and the steroid contraceptive.
  78. Preliminary analysis characteristics of new family planning acceptors in Java and Bali, through third quarter 1971-1972 FY.
  79. Preliminary general practice study of a new contraceptive.
  80. Preliminary studies on metabolic effects of a continuous-dose, progestogen-only, oral contraceptive.
  81. A preliminary study of 60 high school boys, regarding their knowledge and attitudes toward population and family planning; Farabi High School, Karaj.
  82. Prescribing of oral contraceptives to minors [Letter]
  83. Prescribing of oral contraceptives to minors. (Letter to the editor)
  84. Prescribing of oral contraceptives to minors. (Letter to the editor)
  85. Prescribing oral contraceptives to minors [letter]
  86. Prescribing oral contraceptives to minors. (Letter to the editor)
  87. Prescription of oral contraceptives should remain under medical control. [La prescription des anticonceptionnels oraux doit rester un acte medical.]
  88. The present state of oral contraception.
  89. The present status of contraception.
  90. Present status of oral contraceptives: 2. Complications, special considerations, relationship to cancer, cautions.
  91. Principles of family planning for Roman Catholics [letter]
  92. Principles of family planning for Roman Catholics. (Letter to the editor)
  93. Principles of family planning for Roman Catholics. (Letter to the editor)
  94. Principles of family planning for Roman Catholics. (Letter to the editor)
  95. Principles of family planning for Roman Catholics. (Letter to the editor)
  96. Principles of family planning for Roman Catholics. (Letter to the editor)
  97. The pro-con project: research services directed toward the development of a combined agent for disease prophylaxis and contraception, AID/csd-2822.
  98. The problem of birth control.
  99. Problems and prospects in utilizing mass media in family planning.
  100. Problems and prospects of family planning programs background -- Indian experience.
  101. Problems associated with the rhythm method of contraception. (Letter to the editor)
  102. Problems of family planning amongst Africans in Rhodesia.
  103. Problems of human communication in population and family planning work.
  104. A procedure for estimating the demographic effects of a family planning program, illustrated with preliminary Philippine data.
  105. Proceedings of meeting of International Planned Parenthood Federation, Europe Region IUD working group, held in Ljubljana, Yugoslavia, March 30-31, 1972.
  106. Proceedings of the conference on psychology and family planning: August 1-2, 1971.
  107. Progesterone-only contraceptives. (Letter to the editor)
  108. Program Evaluation and Review Technique (PERT) applied to the Korean National Family Planning Program, forms, and records systems.
  109. A programme for planned parenthood.
  110. Progress and failure in population control. (Part of proceedings of Third Annual Meeting of the Family Planning Association of the Americas, Inc., Los Angeles and Palm Springs, Calif., Oct. 31-Nov. 3, 1971.)
  111. Progress in intrauterine contraception. 1. An analysis of clinical cases. Yokohama Central Railroad Hospital.
  112. Progress of family planning program: quarterly report for December 1971-February 1972.
  113. Progress of family planning programme in India.
  114. Progress report on the five-year plan for family planning services and population research programs submitted by the Secretary of Health, Education, and Welfare, January 1972. (Committee Print)
  115. Project report on literacy and population family planning education.
  116. Prolonged secondary amenorrhoea following the use of oral contraceptives.
  117. Proposal of a study on the problems associated with birth control (oral contraception) and cardiovascular disease (myocardial infarction)
  118. A proposal to provide assistance to the Government of Zaire in the creation of a Maternal and Child Health/Family Planning (MCH/FP) Program in the Kinshasa area.
  119. Prostaglandins: the once-a-month birth control pill of the future.
  120. Protocol for a case-control study of the risks for cancer of the breast, ovary, and body of the uterus and for benign breast tumors among users of oral contraceptives.
  121. Pseudoectopic intrauterine contraceptive device (a case report)
  122. Psychiatric aspects of contraceptive utilization.
  123. Psychiatric effects of progesterone and oral contraceptives.
  124. The psychiatrist's role in family planning.
  125. Psychoanalytic consideration of fertility and sexuality in contraception.
  126. Psychologic factors in contraceptive failure.
  127. Psychological aspects of family planning.
  128. Psychological effects of oral contraceptives. [Effetti psichici dei contraccettivi presi oralmente.]
  129. Psychological factors relating to fertility and family planning behavior.
  130. Psychological perspectives of family planning.
  131. Psychology of the misuse and rejection of contraception.
  132. Psychopathologic effects of oral contraception. [Incidences psychopathologiques de la contraception orale.]
  133. Psychosocial aspects of family planning in Kenya.
  134. Psychosocial factors influencing family planning.
  135. Public opinion trends: elective abortion and birth control services to teenagers.
  136. Public opinion, population and family planning.
  137. Puerto Rico (Family planning)
  138. Pulmonary capillary blood volume in women: normal values and the effect of oral contraceptives.
  139. A quest for the elusive chemical male contraceptive.
  140. The questions of abortion and the contraceptive pill. (Letter to the editor)
  141. Research and service in a family planning clinic.
  142. Research in the delivery of female health care: manpower development -- expanded roles for nursing and the nonprofessional in family planning.
  143. Research needs of family planning programme.
  144. Research of Misr Spinning & Weaving Co.'s workers and their reaction to family planning after 7 years.
  145. Research, development and training in family planning communication (project description)
  146. The respective places of abortion, contraception and sterilization in the family planning program in Yugoslavia. [La place respective de l'avortement, de la contraception et de la sterilisation dans le planning familial en Yougoslavie.]
  147. Responsible parenthood and family life education. (Proceedings of the seminar of the Western Pacific Region of the International Planned Parenthood Federation, Hong Kong, September 28-October 1, 1971.)
  148. Results of a contraceptive program based on IUD's in Chile.
  149. The results of abortion methods and future contraceptive practices of patients undergoing therapeutic abortion.
  150. Results of adminstration of the contraceptive Exluton. [Vysledky s podavanim antikoncepcneho preparatu Exluton.]
  151. Results of the oral administration of the contraceptive Metrulen in 12 women during a period of 6 months. [Rezultati ot prilozhenieto na peroralna antikontseptsiya s Metrulen pri 12 zheni v prod'lzhenie na 6 mesetsa.]
  152. Resume of family planning work on Indian railways.
  153. A retrospective study of some aspects of family planning in a rural Kandyan community in Ceylon.
  154. Reversibility of the contraceptive action of copper and zinc in the rat and rabbit.
  155. Review of family planning aspects of family health with special reference to UNICEF/WHO assistance.
  156. A review of trends in family planning information campaigns in the Philippines.
  157. Review of WHO assistance to national health services in family planning in Asia.
  158. Rheumatic disease, abnormal serology, and oral contraceptives.
  159. Risk of stroke with use of oral contraceptives. (Abstract only)
  160. The role and position of sexual activity in planned parenthood. [Uloha a postaveni sexu v planovanem rodicovstvi.]
  161. Role of a private agency in family planning.
  162. The role of AID in family planning.
  163. The role of auxiliary nurse-midwives in family planning.
  164. The role of communications in population and family planning programs.
  165. The role of female sterilization in family planning programs.
  166. Role of growth hormone (GH) in the alterations of carbohydrate metabolism induced by oral contraceptive agents (OCA). (Abstract only)
  167. The role of home economics in family planning: report of a country survey - Nigeria.
  168. The role of home economics in family planning: Thailand.
  169. The role of incentives in family planning.
  170. Role of indigenous midwife in family planning programme.
  171. The role of male counsellors in a family planning service.
  172. Role of medical profession in family planning.
  173. The role of nursing and auxiliary personnel in family planning programmes (Thailand)
  174. Role of panchayat in family planning: massive camp approach.
  175. The role of the pharmacist in family planning.
  176. The role of the traditional midwife in the family planning program. Report of National Workshop to Review Researches into Dukun Activities related to MCH Care and Family Planning.
  177. The role of UNIDO in the field of contraceptives.
  178. Role of universities and medical schools in family planning programme.
  179. The role of voluntary organizations in family planning policy in the 1970s.
  180. The role of women in family planning.
  181. Role prescriptions and extended family planning programmes.
  182. Rural medical profession and family planning.
  183. Sabah (Family planning)
  184. Sarawak (Family planning)
  185. Savings accounts for family planning, an illustration from the tea estates of India.
  186. Scheme for Indian Medical Association's participation on National Family Planning Programme.
  187. Screening for in situ carcinoma of the cervix uteri in a family planning program. [Pesquisa del carcinoma in situ del cuello uterino en un programa de planificacion familiar.]
  188. Seasonal sexual behavior: intrauterine contraceptive devices in a confined troop of Japanese macaques.
  189. Selected bibliography in family planning.
  190. Selection of a family planning method: a Philippine example.
  191. Self-prescribed contraceptive education by the unwillingly pregnant.
  192. Seminar on the Implementation of Population Policies, organised by the International Planned Parenthood Federation, Indian Ocean Regional Office, from Tuesday 4th July to Friday 7th July, 1972 at the Preventive and Social Medicine Lecture Theatre, University of Ceylon, Peradeniya Campus, Peradeniya.
  193. Seminar on the status of women and family planning. (Presented at Istanbul, July 11-24, 1972.)
  194. Serum estradiol in women ingesting combination oral contraceptive steroids.
  195. Serum levels of IgG and alpha-macroglobulin and incidence of cryofibrinogenaemia in women taking oral contraceptives.
  196. Serum levels of phosphorus, magnesium and calcium in women utilizing combination oral or long-acting injectable progestational contraceptives.
  197. Serum magnesium levels of women taking an oral or long-term injectable progestational contraceptive.
  198. Services for males in a family planning program.
  199. Sex and contraception: one man's view.
  200. Sexual behaviour and contraceptive practice of unmarried female undergraduates at Aberdeen University.
  201. Sexuality, contraception and pregnancy among young unwed females in the United States.
  202. A short-term study of knowledge, attitude and practice related to family planning in Midnapore.
  203. Side effects and especially uterine bleeding in women taking oral contraceptives. [Biverkningar hos ett p-pillerklientel med sarskild hansyn til blodningsrubbningar.]
  204. Side effects of depot contraceptives. [Efectos colaterales de los anticonceptivos de deposito.]
  205. Side effects of oral contraceptive medication: a psychosomatic problem.
  206. Side effects of oral contraceptives. [Nebenwirkungen der oralen Kontrazeptiva.]
  207. Sierra Leone (Family planning)

     

  208. Significance of ph of the vagina and uterus in the contraceptive action of intrauterine devices, experimental data. [O znachenii ph vlagalischnoi i vnutrimatochnoi sred v geneze protivozach atochnovo deistviya vnutrimatochnykh kontratseptivov, eksperimentalnie dannie.]
  209. A simplified client record system for family planning programs.
  210. Singapore family planning programme (1966-1970) and its impact on fertility decline, with special reference to ethnic groups.
  211. Singapore: a cost-effect analysis of a family planning program.
  212. Six-week check late for contraception?
  213. Social marketing strategies for diffusing the adoption of family planning.
  214. Social psychological forces influencing fertility and family planning.
  215. Socio-demographic variables relating to fertility and family planning behavior.
  216. Socio-economic and religious factors in the implementation of family planning program in Goa.
  217. Socio-economic returns of family planning programmes: report of an Expert Group meeting.
  218. Socio-economical and medical aspects of planned parenthood.
  219. The sociological aspect of contraception. [La dimension sociologique de la contraception.]
  220. A sociological evaluation of the family planning action programs in rural Korea.
  221. Sociological synthesis: Family planning adoption status.
  222. Some aspects of adoption of family planning practices in Indian villages.
  223. Some aspects of birth control in the Soviet Union.
  224. Some aspects of implementing communication strategy in family planning programmes.
  225. Some aspects of the production, distribution and clinical testing of contraceptives in developing countries: the role of WHO.
  226. Some brief observations on family planning. [Quelques observations sommaires sur le planning familial.]
  227. Some estimates of the potential reduction in the United States infant mortality rate by family planning.
  228. Some findings concerning information sources in the national family planning program. [Algunos resultados sobre fuentes de informacion en el programa nacional de planificacion familiar.]
  229. Some improvements in prescribing oral contraceptives as predicted by a computer simulation. (Abstract only)
  230. Some issues and a checklist relative to the medical evaluation of Family Planning clinics.
  231. Some observations on the changes in capillary resistance in oral contraceptive users.
  232. Some personality correlates of contraceptive use among unmarried female college students.
  233. Some psychosomatic problems of current interest: oral contraception hemodialysis and kidney transplant, jejunocolic shunt. [Quelques problemes psychosomatiques d'interest actuel: contraception orale, hemodialyse et greffe du rein, derivation jejunocolique.]
  234. Some socio-cultural aspects of contraception and sexual behaviour in industrial society.
  235. Some temporal relationships between intrauterine copper wire and its contraceptive action in the rat.
  236. Sources of knowledge about contraception.
  237. Specialisation and skills in family planning techniques.
  238. Sporadic triploid and hexaploid cells in embryonic tissue. Negative relationship to maternal intake of oral contraceptives.
  239. St. Christopher-Nevis (Family planning)
  240. St. Vincent (Family planning)
  241. State administration and financing for family planning services.
  242. Statistical study of the effect of hormonal contraceptives on the voice: first results. [Etude statistique de l'influence des contraceptifs hormonaux sur la voix: premiers resultats.]
  243. Status and prospects of natural family planning.
  244. Status of family planning techniques in the Philippines.
  245. Status of national family planning programmes of developing countries in relation to demographic targets.
  246. Status of national family planning programs of developing countries in relation to demographic targets.
  247. The status of patient instruction and oral contraceptives: 1970.
  248. The status of state policies concerning birth control education.
  249. The status of training in family planning in the Philippines.
  250. Status of women and family planning in India.
  251. Sterilization as a method of family planning.
  252. Steroid contraception and its effects on lactation are a public health dilemma.
  253. Steroid contraceptive therapy may guard against abortion.
  254. Steroid contraceptives and plasma carotenoids.
  255. Strategy for the use of the dukun in the family planning programme.
  256. Studies in family planning and related programs in rural Korea.
  257. Studies of the venous wall and coagulability during oral contraception. [Untersuchungen ueber das Verhalten der venoesen Gefaesswand und der Gerinnungsbereitschaft waehrend oraler Kontrazeption.]
  258. Studies on development of a vaginal preparation providing both prophylaxis against venereal disease, other genital infections and contraception. III. In vitro effect of vaginal contraceptive and selected vaginal preparations of Candida albicans and Trichomonas vaginalis.
  259. Studies on population and family planning in Indonesia.
  260. Studies on some uterine enzymes in the presence of an intrauterine contraceptive device (IUD) in the rat.
  261. Studies on the development of a vaginal preparation providing both prophylaxis against venereal disease and other genital infections and contraception.
  262. A study of 9000 unmarried young women seeking contraceptive advice.
  263. A study of acceptance and continuation of oral contraceptives among women in a rural area.
  264. A study of contraception as related to unwanted pregnancy.
  265. A study of factors explaining variability in family planning performance in different states of India.
  266. A study of family planning exhibition at a rural fair.
  267. Study of some metabolic effects of an oral contraceptive after prolonged use. [Estudio de algunos efectos metabolicos de un gestageno usado en forma prolongada.]
  268. Study of surveillance of women using contraception. [Enquete de surveillance de femmes sous contraception.]
  269. A study of the effectiveness of family planning communications in the Republic of Korea.
  270. A study of the views and attitudes of the emergent educated elite, on family planning contraceptive practice, abortion and sex education (a case study of the students of the University of Ghana)
  271. A study of women who discontinue family planning clinic attendance.
  272. A study on the acceptability and effectiveness of intrauterine contraception in relation to socio-medical variables.
  273. A study on the relationships between postpartum family planning and maternity cares.
  274. Study on the status of woman and family planning.
  275. Study on use-effectiveness and extended use-effectiveness of contraceptive methods.
  276. Successes and failures in a large federally-funded family planning council.
  277. Summary of eleventh national survey on family planning.
  278. Superior mesenteric vein thrombosis and oral contraceptives.
  279. Supplement on 2nd nationwide family planning week.
  280. Supply and demand oriented family planning programs: some notes for a possible extension of current programs in Bangladesh.
  281. Support for free contraception.
  282. Support for psychologists in the population and family planning areas.
  283. In support of family planning education standards.
  284. Surgery in planned parenthood.
  285. The survey method in family planning research and evaluation: the case of Pakistan.
  286. A survey of public health nurses' knowledge and attitudes about family planning.
  287. Survey of the global patterns of contraceptive distribution in the private sector in selected developing countries, Pt. 1.
  288. Survey of the global patterns of contraceptive distribution in the private sector in selected developing countries.
  289. A survey of the role of the general practitioner in family planning.
  290. A survey on attitudes to family planning among 360 Brisbane women.
  291. Swaziland (Family planning)
  292. Symposium on contraception: intrauterine devices.
  293. Syndrome of progressive endometritis associated with intrauterine contraceptive devices.
  294. Synthesis of potential gestagenic components of oral contraceptives. [Sintez potentsialnikh gestagennikh komponentiv oralnikh kontratseptiviv.]
  295. A system model for Family Planning Programme.
  296. Systems approach for evaluation of family planning program in India.
  297. A systems description/analysis of the OEO/OB-GYN University of Florida Family Planning Program.
  298. Tahiti (French Polynesia) (Family planning)
  299. Taiwan (Family planning)
  300. Taiwan's family planning in charts (5th edition)
  301. Target audiences for family planning programmes: a preliminary review of studies.
  302. The tasks and position of the gynecologist in planned parenthood. [Uloha a misto gynekologa v planovanem rodicovstvi.]
  303. Tasks of clinical genetics in planned parenthood. [Ulohy klinickej genetiky v ramci planovaneho rodicovstva.]
  304. Teaching of family planning in medical colleges.
  305. Teenagers, sex and contraception.
  306. Temporary sterilisation of the male by intra-vasal contraceptive device (IVCD)
  307. Ten institutional obstacles to advances in family planning.
  308. A test for fear of pregnancy and its relation to oral contraceptives.
  309. Testing incentive plans for moving beyond family planning.
  310. Thailand (and family planning)
  311. Thailand. (Family planning)
  312. Think piece on district organization of health and family planning services. (India)
  313. The third five-year plan (1972-1976) and revisions of the ten-year plan (1962-1971) of the Korean National Family Planning Program.
  314. Third five-year plan for family planning (1972-1976)
  315. A three-year longitudinal evaluation of the costs of a family planning program.
  316. Thromboembolic disease in women on sequential contraceptives with unopposed ethinyl estradiol.
  317. Thromboembolism and oral contraceptives. (Letter to the editor)
  318. Thrombosis of the digital vessels secondary to oral contraceptives.
  319. Thyroid status in long-term, high-dose oral contraceptive users.
  320. Tonga (family planning)
  321. Toward a family planning program in psychiatric hospitals.
  322. Toward a two-child norm: changing family planning attitudes.
  323. Towards a Unesco family planning communication programme and Unesco/WHO collaboration.
  324. Training in family planning - an annotated bibliography.
  325. Training of family planning workers.
  326. Transient occlusions of the middle cerebral artery associated with oral contraceptives. [Passagere Mediaverschlusse unter oralen Ovulationshemmern.]
  327. Treatment of inflammation of the female genitalia caused by IUD contraception. [Poznamky k leceni zanetu rodidel vzniklycb v souvislosti s IUD antikonce pci.]
  328. Treatment of seborrhea oleosa and acne with contraceptive hormones. [Behandlung der Seborrhoea oleosa und Akne mit kontrazeptiven Hormonen.]
  329. Trends in family planning: the American-Egyptians' case.
  330. Trends in family size preferences and practice of family planning: Taiwan, 1965-1970.
  331. Trial of a sequential oral contraceptive (Serial 28) in a rural area.
  332. A trial of the ovulation method of family planning in Tonga.
  333. Trinidad and Tobago. (Family planning)
  334. Troubleshooting and problem solving with the development and operation of a family planning clinic.
  335. Two pathological and clinical reports on fatal subacute pulmonary embolism in young women. Discussion of the role of contraceptive pills. [Deux observations anatomo-cliniques d'embolies pulmonaires recidivantes subaigues mortelles chez la jeune femme. Discussion du role des anovualtoires oestro-progestatifs.]
  336. Types of oral contraceptives, depression, and premenstrual symptoms.
  337. U.S., Chilean men say "family planning yes," want more contraceptive education services.
  338. Ultrasonic localization of intrauterine contraceptive devices.
  339. Ultrastructural changes found in the endometrium of women using megestrol acetate for contraception.
  340. Undergraduate attitudes towards birth control: new perspectives.
  341. The universal coupon of the Korean National Family Planning Program.
  342. Unusual complication of an intrauterine contraceptive device.
  343. USA government and family planning.
  344. Use effectiveness of family planning in the Philippines, 1970-72.
  345. Use effectiveness study of contraception among 1971 acceptors in East Java.
  346. Use of contraception by the population.
  347. Use of contraceptives and Poland's demographic situation. [Stosowanie srodkow antykoncepcyjnych a sytuacja demograficzna Polski.]
  348. The use of diethylstilbestrol as a post-coital contraceptive.
  349. Use of medroxyprogesterone as a contraceptive. [Utilisation de la medroxyprogesterone a titre contraceptif.]
  350. The use of oral contraceptives as hormonal-withdrawal pregnancy test.
  351. Use of oral contraceptives in urban, rural, and slum areas.
  352. The use of paramedical personnel in field programmes for family planning in Indonesia.
  353. The use of radio in family planning.
  354. Use of the intrauterine contraceptive device in the treatment of post-traumatic synechiae. [L'utilisation du pessaire contraceptif intra-uterin dans le traitement des synechies d'origine traumatique.]
  355. The use of traditional media in family planning programs in rural Java.
  356. The use of ultrasound B-mode scanning in the localization of intrauterine contraceptive devices.
  357. Use-effectiveness in contraception. (Letter to the editor)
  358. Using a model as a practical management tool for family planning programs.
  359. Uterine progesterone system for contraceptive use: patient information.
  360. Uterine uptake of (6,7-tritiated) oestradiol in the presence of intrauterine contraceptive device in cyclic and pregnant rats.
  361. Utilization of contraceptive methods in Belgium by mothers of children aged 0 to 3 years. [Utilisation des moyens contraceptifs en Belgique -- par les meres d'enfants ages de 0 A 3 ans.]
  362. Utilization of traditional birth attendants for recruiting family planning acceptors and re-supplying of oral contraceptives: Malaysia's experience.
  363. Vascular complications of oral contraception thrombosis -- arterial hypertension. [Les complications vasculaires de la contraception orale--thromboses -- hypertension arterielle.]
  364. Vasectomy as method of birth control -- a report of 8751 vasectomies done in Ajmer District. Ajmer District. 2.
  365. Vasectomy: Canada's newest family planning method.
  366. Vasectomy: the truth and consequences of the newest form of birth control - male sterilization.
  367. Venereal disease among Nigerian women attending intra-uterine contraceptive device clinics.
  368. Venous distensibility during pregnancy and oral contraceptive therapy.
  369. Vitamin C requirements and oral contraceptives.
  370. Voluntary agencies and Tata Family Planning Programme.
  371. Voluntary interruption of pregnancy: its psychiatric and contraceptive correlates.
  372. Voluntary interruption of pregnancy: psychiatric and contraceptive technique patterns pre- and postoperatively.
  373. Voluntary sterilization: the simple surgical method of contraception. (Vasectomy)
  374. Ways to make family planning popular in tribal villages.
  375. What is wrong with family planning services?
  376. What Louisiana is doing in family planning.
  377. What our women know think and do about birth control.
  378. When can we expect a contraceptive vaccine?
  379. Who needs family planning?

     

  380. WHO reports on health aspects of family planning.
  381. Women, sterilization, family planning: highlight 20th annual meeting. ACOG -- 1972.
  382. The work of the family planning association.
  383. The work of the family planning association: the history of the South Australian Branch.
  384. A working manual for nurses: utilization of traditional village birth attendants (Kampong Bidan) for family planning in Malaysia.
  385. Workshop on the Development of Education and Information Materials on Family Health (Family Planning, Maternal and Child Health, Nutrition), Manila, Philippines, February 8-22, 1972. Final report.
  386. The world's laws on voluntary sterilization for family planning purposes.
  387. X-ray appearance of intrauterine contraceptive devices.
  388. Young men will use contraception.
  389. Youth F.P. (family planning) seminar in Lagos.
  390. Ypsilon: a new silicone-covered stainless steel intrauterine contraceptive device.
  391. Abortion or contraception? (Letter to the editor)
  392. Attitude clusters in birth control counseling by social workers.
  393. Contraception and pulmonary embolism.
  394. Experience in the use of intrauterine contraceptives. [Opyt primeneniya vnutrimatochnykh kontratseptivov.]
  395. An experimental model of intrauterine contraception. [Eksperimentalnaya model vnutrimatochnoi kontratseptsii.]
  396. Family planning patterns in Sierra Leone.
  397. A five-year comparison of the continuation rates between women using Loop D and oral contraceptives.
  398. Further results of using Lethilan intrauterine contraceptives (LIC-66. [Dalneischie rezultaty primeneniya letilanovykh vnutrimatochnykh kontratseptivov LVK-66.]
  399. Galactorrhea and contraceptive practices.
  400. Hormonal contraceptives and dermatology.
  401. Hormone analytic studies during treatment with new contraceptive agents. [Hormonanalytische Untersuchungen unter Behandlung mit neuartigen Kontrazeptiva.]
  402. Hypertension, oral contraceptive agents, and conjugated estrogens.
  403. The mechanism of action of hormonal contraceptives. [O mekhanizme deistviya gormonalnykh kontratseptivov.]
  404. Menstrual bleeding with intrauterine contraceptive devices.
  405. On the history of hormonal contraception: II. Otfried Otto Fellner (1873-19??) and estrogens as antifertility hormones.
  406. Oral contraceptives and exacerbation of lupus erythematosus.
  407. Ovulation suppressor contraception and depression.
  408. Polypoid hyperplasia of the cervical glands on the external os uteri with epithelial agitation after hormonal contraception. [Polypoide Zervixdrusenhyperplasien am ausseren Muttermund mit Epithelunruhe nach hormonaler Kontrazeption.]
  409. Prolonged secondary amenorrhoea after oral contraceptive therapy.
  410. Screening for heterozygous al-antitrypsin deficiency: a provocative test with diethylstilbestrol and effect of oral contraceptives.
  411. A study of contraceptive effectiveness and incidence of side effects with the use of the Majzlin spring.
  412. Various findings on the mechanism of action of the contraceptive drug mesgestranol. [Nekotorie dannie o mekhanizme deistviya gormonalnovo kontratseptivnova s redstva megestranola.]
  413. Psychology of contraception. [Psicologia de la anticoncepcion.]
  414. Psychology of contraceptive failure.
  415. Psychology of the misuse and rejection of contraception.
  416. Psychosexual response and attitudes toward family planning.
  417. Psychosomatic aspects of family planning.
  418. Psychosomatic factors in amenorrhea after oral contraception. [Psykosomatiska faktorer vid amenorre efter oral antikoception.]
  419. Psychosomatic symptoms associated with oral contraceptives--can they be reduced?
  420. Public welfare and family planning.
  421. Pulmonary embolism and oral contraceptives.
  422. Pulmonary infarction following the use of an oral contraceptive: in a woman of blood group A.
  423. Qualitative evaluation of family planning proposals and programs: a systems approach.
  424. Quality control of non-ethical contraceptive products.
  425. Quantitative changes in plasma amino acids induced by oral contraceptives.
  426. R 2323--an original contraceptive compound.
  427. Ranking of contraceptive methods by levels of effectiveness.
  428. Rate of heme destruction and endogenous carbon monoxide production (VCO) of normal women following administration of oral contraceptive compound Norinyl 1 + 80.
  429. The re-establishment of postpartum ovulation and contraception.
  430. Recent advances in contraceptive technology.
  431. Recent changes in official, legal and political attitudes to contraception.
  432. Recent trends and developments in medical education in family planning and human sexuality--a survey report.
  433. Regional Course in the Production and Use of Mass Media for Family Planning Programmes in Asia, Seoul, Republic of Korea, 14 September-10 October, 1970. Final report.
  434. Relation between male occupation and some aspects of family planning. [Relacion de la ocupacion masculina y algunos aspectos de la planeacion familiar.]
  435. Relationships between contraception and the individual, the society and the culture. [Incidences de la contraception sur l'individu, la societe et la culture.]
  436. The relative expressed estrogenicity of the newer low-dose oral contraceptives.
  437. Report from Danish Board on Adverse Reactions. 13. Reports on adverse reactions with use of oral contraceptives during the period 1 May 1968-1 November 1970. [Meddelelse fra sundhedsstyrelsens bivirkingsnaevn. 13. Inberetninger om bivirkninger under anvendelse af perorale antikonceptionsmidler i perioden 1. mai 1968-1. November 1970.]
  438. Report of a workshop: interaction between oral contraceptives and essential dietary nutrients.
  439. Report of rapporteur. (Contraceptive research and development)
  440. Report of rapporteur. (Family planning programs)
  441. Report of the interregional meeting of experts on the social welfare aspects of family planning.
  442. Report of the IPPF/UNESCO Experts Meeting on Clearing House Facilities for Communication Materials and Equipment for Family Planning and Population Activities. Held in London at the IPPF Central Office, 18-20 Lower Regent Street, London, S.W.1.
  443. Report of the Secretary of Health, Education, and Welfare submitting five-year plan for family planning services and population research programs, October 12, 1971. (Committee Print)
  444. Report on family planning clinics conducted in the Cape Town municipal area from 1960 to 1969.
  445. 3-months contraception with norethisterone enanthate. Clinical and biochemical parameters. [Zur 3-Monats-Kontrazeption mit Norethisterononanthat. Klinische biochemi sche Untersuchungen.]
  446. Abnormal tryptophan metabolism in pregnancy and with the oral contraceptive pill. 2. Relative levels of vitamin B-6-vitamers in cord and maternal blood.
  447. Abnormal tryptophan metabolism in pregnancy and with the oral contraceptive pill. 1. Specific effects of an oral estrogenic contraceptive steroid on the tryptophan oxygenase and two aminotransferase activities in livers of ovariectomized-adrenalectomized rats.
  448. Abortion and contraception in family planning: a commentary.
  449. Abortion and contraception: demographic implications.
  450. Abortion or contraception?
  451. Abortion or Contraception?
  452. Abortion or contraception?
  453. Abortion or Contraception?
  454. Abortion or contraception?
  455. Abortion without birth control.
  456. Abortion, contraception, sterilization: the camel's nose.
  457. Accelerating family planning: a manual for field workers.
  458. Acceptability of contraceptive methods. [Zur Akzeptabilitat contrazeptiver Methoden.]
  459. Acceptability of Depo-Provera as a reliable contraceptive method.
  460. Acne vulgaris and oral contraceptives.
  461. Activation of Factor 7 in oral contraception.
  462. The activity of certain endometrial enzymes in cases of several years' presence of intrauterine contraceptive devices in uterine cavity.
  463. Adenocarcinoma of the uterine body following use of intrauterine contraceptive device.
  464. Administration of oral contraceptives and gynecologic examination. [P-pille ordination og gynaekologisk undersogelse.]
  465. Administrative concerns in family planning in six developing countries.
  466. Adolescent attitudes toward abortion: effects on contraceptive practice.
  467. Adrenocorticotrophin-test applied on women taking oral contraceptives.
  468. Advanced course in medical and surgical techniques in family planning.
  469. Adverse effects of oral contraceptives.
  470. Advertising family planning.
  471. Against nature: the use and misuse of birth control.
  472. Albumin metabolism in female mice treated with progestogen and oestrogen components in oral contraceptives.
  473. An all India survey of family planning practices.
  474. Alteration of rastin bloodsugar, 4 glucosetolerance, insulin response, free fatty acids and triglyceride during oral contraception.
  475. Alterations in the levels of some serum proteins and serum enzymes during treatment with an sequential type oral contraceptive. [Aendret niveau for nogle serumproteiner og serumenzymer under behandling med et oralt antikonceptionsmiddel af sekvenstype.]
  476. Amenorrhea and infertility after oral contraception.
  477. Amenorrhea following oral contraceptives.
  478. Analysis of "drop-outs" in oral contraceptives.
  479. Analysis of June 1969 and June 1970, Family Planning Acceptor Coupons.
  480. Analysis of the contraceptive and abortion control program in Chile (1964-1969) [Analisis del programa anticonceptivo y de control de aborto en Chile--1964-1969.]
  481. Analytical review of ten years of family planning programs in Korea.
  482. Angiographically verified cerebrovascular disease in young women on oral contraceptives without previous neurological illness.
  483. Annual report on family planning acceptors at Philippine program clinics: 1970.
  484. Anovulation following use of oral contraceptives: a review.
  485. Antinuclear antibodies, rheumatoid factor and C-reactive protein in serum of normal women using oral contraceptives.
  486. Antithrombin III depression and thrombin generation acceleration in women taking oral contraceptives.
  487. Aorto-iliac occlusion in women using oral contraceptives.
  488. Appendix 2: A review of research related to family planning in tropical Africa.
  489. The application of intrauterine contraceptive devices as one of the methods of family planning. [Primenenie vnutrimatochnykh protivozachatochnykh credstv kak odin iz metodov planirovaniya semi.]
  490. An appraisal of the Population Project of the Rural Health Research Center at Narangwal India: the integration of family planning and rural health services at the village level.
  491. Are oral contraceptives contraindicated after pregnancy hepatosis. [A preventivtabletter kontraindicerade efter genomgangen graviditetshep atos?]
  492. Arterial hypertension and oral contraception. [Hypertensio arterialis og peroral antikonception.]
  493. Arterial hypertension and oral contraceptives) [Hypertension arterielle et contraceptifs oraux.]
  494. Asian employers' seminar on population and family planning, New Delhi, March 22-27, 1971.
  495. Aspects of differentiated indications and choice of hormonal contraceptives. [Gesichtspunkte einer differenzierten Indikationsstellung und Auswahl hormoneller Kontrazeptiva.]
  496. Assessment of contraceptives methods in humans.
  497. An assessment of family planning programmes.
  498. Attacks of acute intermittent porphyria due to oral contraceptives. Report of a clinical case. [Crisi di porfiria acuta intermittente scatenate dall'uso di contracettivi orali. Segnalazioni di un caso clinico.]
  499. Attenders at a contraceptive clinic for single women.
  500. Attitude of the two religious groups towards family planning.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.